Opeayo Ogundiran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Opeayo Ogundiran has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
George Sie Williams
WHO Regional Office for Africa
2 shared publicationsAbiodun Oyefabi
World Health Organization Country Office, Abuja, Nigeria
1 shared publicationAbou Salam Gueye
WHO Regional Office for Africa
1 shared publicationAmaka Onyiah
World Health Organization Regional Office for Africa, Brazzaville, Congo
1 shared publication- Bo Wang
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore
1 shared publication - Chikwe Ihekweazu
Nigeria Centre for Disease Control, Abuja, Nigeria
1 shared publication
Latest Publications
- Open Access
- 21 January 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1697663
Event-based surveillance in the WHO African region: baseline implementation before the COVID-19 pandemic
Event-based surveillance (EBS) is a critical component of epidemic intelligence, supporting the timely detection of unusual public health events. However, prior to the COVID-19 pandemic, the status of EBS implementation across the WHO African region was not well documented. This study establishes a regional baseline of EBS modalities in place before the pandemic to inform future surveillance system evaluation and strengthening. We conducted a cross-sectional survey across all 47 WHO Member States in the African region between December 2019 and February 2020. A structured questionnaire was disseminated through WHO Country Offices to assess the presence, characteristics, and functionality of EBS modalities—including health facility-based EBS (HEBS), community-based surveillance (CBS), and media monitoring. Quantitative data were analyzed descriptively, while qualitative responses underwent thematic analysis. Thirty-seven countries (78.7%) responded, of which 84% ( n = 31) had implemented at least one form of EBS. HEBS was the most commonly reported modality (67.6%), followed by CBS (54.1%) and media monitoring (29.7%). Cholera, acute flaccid paralysis, measles, and meningitis were the most frequently detected conditions. While mobile phones were the primary channel for reporting, challenges included resource constraints and infrastructure gaps. Radio was the most widely used media source due to limited access to internet-based tools. Countries widely recognized EBS as a national priority but cited the need for sustainable financing, tools, and trained personnel. By early 2020, most countries in the region had adopted EBS, though implementation varied in scope and maturity. The COVID-19 pandemic catalyzed expansion of many modalities, offering an opportunity to institutionalize gains. Strengthening EBS systems will require sustained investment, intersectoral coordination, and context-appropriate tools aligned with national capacities.
- 21 January 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1697663
Open AccessEvent-based surveillance in the WHO African region: baseline implementation before the COVID-19 pandemic
Event-based surveillance (EBS) is a critical component of epidemic intelligence, supporting the timely detection of unusual public health events. However, prior to the COVID-19 pandemic, the status of EBS implementation across the WHO African region was not well documented. This study establishes a regional baseline of EBS modalities in place before the pandemic to inform future surveillance system evaluation and strengthening. We conducted a cross-sectional survey across all 47 WHO Member States in the African region between December 2019 and February 2020. A structured questionnaire was disseminated through WHO Country Offices to assess the presence, characteristics, and functionality of EBS modalities—including health facility-based EBS (HEBS), community-based surveillance (CBS), and media monitoring. Quantitative data were analyzed descriptively, while qualitative responses underwent thematic analysis. Thirty-seven countries (78.7%) responded, of which 84% ( n = 31) had implemented at least one form of EBS. HEBS was the most commonly reported modality (67.6%), followed by CBS (54.1%) and media monitoring (29.7%). Cholera, acute flaccid paralysis, measles, and meningitis were the most frequently detected conditions. While mobile phones were the primary channel for reporting, challenges included resource constraints and infrastructure gaps. Radio was the most widely used media source due to limited access to internet-based tools. Countries widely recognized EBS as a national priority but cited the need for sustainable financing, tools, and trained personnel. By early 2020, most countries in the region had adopted EBS, though implementation varied in scope and maturity. The COVID-19 pandemic catalyzed expansion of many modalities, offering an opportunity to institutionalize gains. Strengthening EBS systems will require sustained investment, intersectoral coordination, and context-appropriate tools aligned with national capacities.
- Open Access
- 29 September 2025
- Published by Springer Nature in Conflict and Health
- Vol. 19 (1) , 1-11
A review of the performance of the early warning alert and response system (EWARS) in conflict-affected Borno State, Nigeria: a five-year descriptive analysis
The northeastern region of Nigeria has been experiencing a protracted humanitarian crisis, characterized by conflict, displacement, and a severely disrupted health system. The Early Warning Alert and Response System (EWARS) was implemented in 2016 to strengthen disease surveillance in this challenging context. This study employed a descriptive design to evaluate the performance of EWARS in Borno State, Nigeria, over a five-year period (2016–2021). The data sources included weekly health facility reports and the EWARS alert log. Key performance indicators, including timeliness and completeness of reporting, were analyzed. EWARS coverage expanded significantly, reaching 341 health facilities across 25 local government areas. The timeliness of reporting ranged from 6 to 85%, with a median of 65.5% (95% CI: 59–73%). A statistically significant positive Pearson correlation was observed between timeliness and the duration of implementation (r = 0.45, p < 0.001). Completeness of reporting ranged from 42 to 96%, with a median of 68% (95% CI: 62.0–76.25%) and a weaker but significant positive correlation (r = 0.19, p < 0.001). A total of 13,737 alerts were generated, of which 89.6% were verified within 24 hours. However, only 0.1% required an immediate public health response. While systematically recorded data on response activities were limited, verified alerts—particularly for measles and cholera—reportedly triggered vaccination campaigns, case investigations, and WASH interventions. The EWARS system demonstrated significant operational value in strengthening disease surveillance and triggering early warning alerts in the conflict-affected Borno State. Despite not meeting all national performance targets, the system showed improvements over time and supported early detection and verification of potential outbreaks. Its utility as a first-line surveillance tool is evident, though future efforts should prioritize integrating response documentation and event-based surveillance components to strengthen public health impact assessment.
- 29 September 2025
- Published by Springer Nature in Conflict and Health
- Vol. 19 (1) , 1-11
Open AccessA review of the performance of the early warning alert and response system (EWARS) in conflict-affected Borno State, Nigeria: a five-year descriptive analysis
The northeastern region of Nigeria has been experiencing a protracted humanitarian crisis, characterized by conflict, displacement, and a severely disrupted health system. The Early Warning Alert and Response System (EWARS) was implemented in 2016 to strengthen disease surveillance in this challenging context. This study employed a descriptive design to evaluate the performance of EWARS in Borno State, Nigeria, over a five-year period (2016–2021). The data sources included weekly health facility reports and the EWARS alert log. Key performance indicators, including timeliness and completeness of reporting, were analyzed. EWARS coverage expanded significantly, reaching 341 health facilities across 25 local government areas. The timeliness of reporting ranged from 6 to 85%, with a median of 65.5% (95% CI: 59–73%). A statistically significant positive Pearson correlation was observed between timeliness and the duration of implementation (r = 0.45, p < 0.001). Completeness of reporting ranged from 42 to 96%, with a median of 68% (95% CI: 62.0–76.25%) and a weaker but significant positive correlation (r = 0.19, p < 0.001). A total of 13,737 alerts were generated, of which 89.6% were verified within 24 hours. However, only 0.1% required an immediate public health response. While systematically recorded data on response activities were limited, verified alerts—particularly for measles and cholera—reportedly triggered vaccination campaigns, case investigations, and WASH interventions. The EWARS system demonstrated significant operational value in strengthening disease surveillance and triggering early warning alerts in the conflict-affected Borno State. Despite not meeting all national performance targets, the system showed improvements over time and supported early detection and verification of potential outbreaks. Its utility as a first-line surveillance tool is evident, though future efforts should prioritize integrating response documentation and event-based surveillance components to strengthen public health impact assessment.
- Open Access
- 23 October 2018
- Published by Springer Nature in Virology Journal
- Vol. 15 (1) , 1-6
A new hepatitis E virus genotype 2 strain identified from an outbreak in Nigeria, 2017
In 2017 the Nigerian Ministry of Health notified the World Health Organization (WHO) of an outbreak of hepatitis E located in the north-east region of the country with 146 cases with 2 deaths. The analysis of the hepatitis E virus (HEV) genotypes responsible for the outbreak revealed the predominance of HEV genotypes 1 (HEV-1) and 2 (HEV-2). Molecular data of HEV-2 genomes are limited; therefore we characterized a HEV-2 strain of the outbreak in more detail. The full-length genome sequence of an HEV-2 strain (NG/17–0500) from the outbreak was amplified using newly designed consensus primers. Comparison with other HEV complete genome sequences, including the only HEV-2 strain (Mex-14) with available complete genome sequences and the availability of data of partial HEV-2 sequences from Sub-Saharan Africa, suggests that NG/17–0500 belongs to HEV subtype 2b (HEV-2b). We identified a novel HEV-2b strain from Sub-Saharan Africa, which is the second complete HEV-2 sequence to date, whose natural history and epidemiology merit further investigation.
- 23 October 2018
- Published by Springer Nature in Virology Journal
- Vol. 15 (1) , 1-6
Open AccessA new hepatitis E virus genotype 2 strain identified from an outbreak in Nigeria, 2017
In 2017 the Nigerian Ministry of Health notified the World Health Organization (WHO) of an outbreak of hepatitis E located in the north-east region of the country with 146 cases with 2 deaths. The analysis of the hepatitis E virus (HEV) genotypes responsible for the outbreak revealed the predominance of HEV genotypes 1 (HEV-1) and 2 (HEV-2). Molecular data of HEV-2 genomes are limited; therefore we characterized a HEV-2 strain of the outbreak in more detail. The full-length genome sequence of an HEV-2 strain (NG/17–0500) from the outbreak was amplified using newly designed consensus primers. Comparison with other HEV complete genome sequences, including the only HEV-2 strain (Mex-14) with available complete genome sequences and the availability of data of partial HEV-2 sequences from Sub-Saharan Africa, suggests that NG/17–0500 belongs to HEV subtype 2b (HEV-2b). We identified a novel HEV-2b strain from Sub-Saharan Africa, which is the second complete HEV-2 sequence to date, whose natural history and epidemiology merit further investigation.